Steven Cohen's ORKA Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 600,000 shares of Oruka Therapeutics, Inc. (ORKA) worth $18.19 M, representing 0.02% of the portfolio. First purchased in 2024-Q3, this short-term holding has been held for 6 quarters.
Based on 13F filings, Steven Cohen has maintained this position in ORKA for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2025, adding 707,002 shares. Largest reduction occurred in Q4 2025, reducing 437,002 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Oruka Therapeutics (ORKA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Oruka Therapeutics (ORKA) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -437,002 | Reduce 42.14% | 600,000 | $30.31 |
| Q3 2025 | +707,002 | Add 214.24% | 1.04 M | $19.23 |
| Q2 2025 | -12,399 | Reduce 3.62% | 330,000 | $11.21 |
| Q1 2025 | -18,333 | Reduce 5.08% | 342,399 | $10.26 |
| Q4 2024 | -121,598 | Reduce 25.21% | 360,732 | $19.39 |
| Q3 2024 | +482,330 | New Buy | 482,330 | $24.51 |
Steven Cohen's Oruka Therapeutics Investment FAQs
Steven Cohen first purchased Oruka Therapeutics, Inc. (ORKA) in Q3 2024, acquiring 482,330 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Oruka Therapeutics, Inc. (ORKA) for 6 quarters since Q3 2024.
Steven Cohen's largest addition to Oruka Therapeutics, Inc. (ORKA) was in Q3 2025, adding 1,037,002 shares worth $19.94 M.
According to the latest 13F filing for Q4 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 600,000 shares of Oruka Therapeutics, Inc. (ORKA), valued at approximately $18.19 M.
As of the Q4 2025 filing, Oruka Therapeutics, Inc. (ORKA) represents approximately 0.02% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Oruka Therapeutics, Inc. (ORKA) was 1,037,002 shares, as reported at the end of Q3 2025.